VIP and Gut Inflammation: Why Two Mouse Studies Pointed Different Ways
One study favored VIP inhibition; another found VIP helped protect the intestinal barrier. The model and endpoint change the interpretation.
Updated October 10, 2026Cognitive & Neuropeptides · Source-reviewed dossier
Source-Reviewed Research Dossier
VIP is a small signaling peptide the body makes naturally in nerves and immune cells. It helps widen blood vessels, release fluid from glands, and adjust immune-cell activity through two receptors, VPAC1 and VPAC2. Because this signaling system touches the gut, circulation and inflammation, researchers use VIP as a laboratory tool. The studies collected here are an immune review and preclinical experiments in gut cells and mice after radiation injury. They describe mechanisms and model-specific findings, not human treatment results. They do not show whether any particular supplied material is pure, correctly identified or active.
Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; request the applicable product specification and ask which lot records are available before ordering.
Product identity
Literature reference parameters
Identity safeguard Reference identifiers above describe the literature compound record. Confirm the supplied form, formula, molecular weight, purity and storage conditions against the applicable product specification and any available lot records.
A target-to-pathway view grounded in the linked research records.
Reported research findings
Reported outcomes are paired with their experimental model and evidence boundary.
A review summarized VIP effects across innate and adaptive immune-cell pathways.
A mechanistic review does not establish efficacy for a supplied peptide material.
Read the primary studyA 2024 study reported secretory-differentiation and injury outcomes in radiation-exposed intestinal models.
The model does not establish human treatment or catalog-lot quality.
Read the primary studyCatalog options
Pack-level catalog data; lot-level controls remain document-specific.
Single-component peptide · 5 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Single-component peptide · 10 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
A listed document is not proof of availability for this lot. Ask the team to confirm the current COA status and the scope of any other records before ordering.
Analytical interpretation
Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.
Open the Quality & Documentation HubHPLC area ≠ assayA dominant peak does not establish target mass fraction.
Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.
Counterions affect contentWater, salt form and solvents change the as-is composition.
Storage needs a data basisShipping practice is not the same as stability evidence.
Evidence map
Published studies and regulatory records, not customer testimonials or usage guidance.
A mechanistic review does not establish efficacy for a supplied peptide material.
View primary recordThe model does not establish human treatment or catalog-lot quality.
View primary recordThird-party publications selected for direct relevance.
Review. 2013. PMID 22139413.
Preclinical study. 2024. PMID 39380035.
Concise answers for researchers comparing identity, evidence and catalog variants.
Two directions stand out. A review maps VIP as a wide-ranging immune regulator acting through VPAC receptors and cAMP. A preclinical study found VIP nudged intestinal cells toward a secretory fate, altered progenitor-cell division, and lessened radiation injury in organoids and in mice given abdominal radiation. These describe mechanism and model outcomes, not confirmed benefits for people. Neither finding speaks to the quality, purity or performance of any particular catalog material.
Published biology and animal studies say nothing about the purity, identity or handling of a commercial research vial. A catalog listing, a purity report and a biological finding answer three different questions. Existing product documents control identity and lot release. The reference studies control statements about mechanism and model-specific outcomes. Keeping these layers apart is why this page reports both the promising preclinical recovery findings and the plain fact that human therapeutic evidence is not supplied here.
The evidence base is broad in physiology but therapeutic intervention evidence remains indication-specific and frequently preclinical.
No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.
A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.
Store at -20 °C, protected from light and moisture. After reconstitution, aliquot and avoid repeated freeze-thaw cycles. Confirm the applicable storage statement on the product-specific specification and lot documentation.
Knowledge center
Owned educational content connected to this family.
One study favored VIP inhibition; another found VIP helped protect the intestinal barrier. The model and endpoint change the interpretation.
Updated October 10, 2026Knowledge tools
Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.
Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.
Technical procurement
Selected: VIP5 · 5 mg × 10 vials
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.